机构地区:[1]浙江大学医学院呼吸药物研究实验室,杭州310058
出 处:《中国药学杂志》2012年第7期504-512,共9页Chinese Pharmaceutical Journal
基 金:浙江省中医药重点研究计划资助项目(2008ZA014)
摘 要:目的观察在不同时期给予留兰香油对博莱霉素引起的小鼠肺纤维化病理改变及肺组织中肿瘤坏死因子-α(TNF-α)、转化生长因子-β1(TGF-β1)、基质金属蛋白酶-9(MMP-9)、金属蛋白酶抑制剂-1(TIMP-1)及α-平滑肌肌动蛋白(α-SMA)表达的影响。方法 ICR小鼠一次性气道内滴入博莱霉素建立肺纤维化模型,实验动物分为留兰香油治疗组和预防组,分别于造模后第8天和第1天开始给予留兰香油灌胃3周和4周。每7 d记录小鼠体重、死亡率;肺组织切片行HE、Masson染色观察气道炎症及纤维化程度,并对病理图片进行形态学测量分析;测定肺组织中羟脯氨酸(hydroxyproline)、TNF-α、TGF-β1、MMP-9及TIMP-1含量;测定肺组织中α-SMA表达水平。结果留兰香油14、42、140 mg.kg-1预防组能明显减少组织纤维化区域,部分肺泡结构得以保留,肺泡间隔胶原沉积减少;留兰香油14和140 mg.kg-1预防组能够明显降低肺组织中羟脯氨酸、TGF-β1和MMP-9含量;留兰香油14、42、140 mg.kg-1预防组能够明显降低肺内α-SMA表达水平。留兰香油治疗组除14 mg.kg-1组明显减弱α-SMA表达外对其余各项指标均没有明显作用。结论早期给予留兰香油对博莱霉素引起的小鼠肺纤维化有减轻作用,其机制可能是通过降低肺组织中MMP-9及TGF-β1的含量,减少基底膜断裂,减少成纤维细胞增殖和转化,减少肌成纤维细胞α-SMA表达及细胞外基质的合成,对肺纤维化初期起到干预作用。OBJECTIVE To investigate the effect of spearmint oil given at different period of time on pathological changes and the expression of tumor necrosis factor-a(TNF-a) , transforming growth factor-β1 (TGF-β1), matrix metalloproteinases-9 (MMP-9) , tissue inhibitor of metalloproteinase-1 (TIMP-1) and a-smooth muscle actin(a-SMA) in mice with bleomycin-induced pulmonary fibrosis. METHODS Pulmonary fibrosis was induced by intratracheal instillation of bleomycin in ICR mice, then the animals were ran- domly divided into spearmint oil therapeutic and preventive groups. One day after intratracheal instillation of bleomycin, the mice in preventive group were treated with spearmint oil for 4 weeks; while those in therapeutic groups were given spearmint oil 8 days after administering of bleomycin for 3 weeks. The body weight and mortality were recorded every week; the pathologic changes of lung tissue were observed by HE and Masson staining; the hydroxyproline content was determined; the levels of TNF-et, TGF-β1, MMP-9 and TIMP-1 were measured by ELISA; the expression of a-SMA was observed by immunochemistry. RESULTS In the preventive groups, spearmint oil of 14, 42 and 140 mg. kg-1 significantly decreased the fibrosis area and reduced collagen deposition while preserving some alveolar structure; spearmint oil of 14 and 140 mg . kg-1 significantly decreased hydroxyproline, TGF-β1 and MMP-9 Content; spearmint oil of 14, 42, 140 mg . kg -1 significantly attenuated the expression of a-SMA. In the therapeutic groups, spearmint oil had no significant effect except that the 14 mg . kg-1 group obviously attenuated the expression of a-SMA. CONCLUSION Spearmint oil given at early period attenuates bleomycin-induced pulmonary fibrosis in mice, the mechanism may include decreasing basemembrane disruption, inhibiting fibroblast, proliferation and transformation, reducing the expression of a-SMA as well as the formation and accumulation of ECM through decreasing the contents of MMP-9 and TGF-β1 in lung tissue.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...